Trial · NCT05946551
Outcomes20
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 20
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants That Had Any Confusion Over How to Take the Study Drug, Including Which Pill to Take, When to Take it, or How Many to Take | End of the Treatment Phase at 12 weeks | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Number of Participants That Had Trouble Adhering to the Study Drug Schedule | End of the Treatment Phase at 12 weeks | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Number of Participants That Had Any Difficulty Using the REDCap Interface. | End of the Treatment Phase at 12 weeks | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Number of Participants That Prefer Participating in This Virtual Study | End of the Treatment Phase at 12 weeks | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Number of Participants Satisfied With Their Opportunities to Interact With Study Staff | End of the Treatment Phase at 12 weeks | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Number of Participants That Felt They Could Reach Study Staff if Needed | End of the Treatment Phase at 12 weeks | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Number of Participants That Felt That Study Staff Was Available and Easy to Contact to Report Any Adverse Effects | End of the Treatment Phase at 12 weeks | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Number of Participants That Felt That the Amount of Information Collected in Each Series of Surveys Was Acceptable | End of the Treatment Phase at 12 weeks | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Number of Participants That Felt That the Frequency in Which the Information Was Collected Was Acceptable | End of the Treatment Phase at 12 weeks | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Improvement Rating | End of the Treatment Phase at 12 weeks | Score on a scale | MEAN | |
| PRIMARY | Quality of Life (QoL) Score Rating | End of the Treatment Phase at 12 weeks | Score on a scale | MEAN | |
| PRIMARY | Interest Score | End of the Treatment Phase at 12 weeks | score on a scale | MEAN | |
| SECONDARY | Proportion of Survey Completion | End of the Treatment Phase at 12 weeks | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Proportion of Study Drug Adherence | End of the Treatment Phase at 12 weeks | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Proportion of Lost to Follow Up (LFUP) | End of the Treatment Phase at 12 weeks | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Proportion of Voluntary Termination | End of the Treatment Phase at 12 weeks | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Adverse Events (AEs) Incidence | End of the Treatment Phase at 12 weeks | number of adverse events | MEAN | |
| SECONDARY | Serious, Unexpected Suspected Adverse Reactions (SUSAR) Incidence | End of the Treatment Phase at 12 weeks | Number of SUSARs | NUMBER | |
| SECONDARY | Study-wide Serious Adverse Events (SAEs) Incidence | End of the Treatment Phase at 12 weeks | Number of SAEs | NUMBER | |
| SECONDARY | Number of Discontinuations or Temporary Suspensions of IP | End of the Treatment Phase at 12 weeks | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05946551/outcomes